Benzamil (Benzylamiloride) is used as an inhibitor of the Na⁺/Ca²⁺ exchanger (NCX) (IC₅₀ ~ 100 nM); a non-selective blocker of degenerin/epithelial sodium channels (ENaC) that enhances myogenic vasoconstriction; an inhibitor of TRPP3-mediated Ca²⁺-activated currents (IC₅₀ = 1.1 μM); and an inhibitor of neuronal and heterologously expressed small-conductance Ca²⁺-activated K⁺ channels. It has also been used in vivo to prolong survival in stroke-prone spontaneously hypertensive rats (SHRSP) when administered subcutaneously at 0.7 mg/kg/day.